Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV002227356 | SCV002506236 | uncertain significance | HNSHA due to aldolase A deficiency | 2022-01-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002227356 | SCV003453492 | uncertain significance | HNSHA due to aldolase A deficiency | 2023-12-21 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 54 of the ALDOA protein (p.Glu54Lys). This variant is present in population databases (rs199852002, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with ALDOA-related conditions. ClinVar contains an entry for this variant (Variation ID: 1679477). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Mayo Clinic Laboratories, |
RCV004793745 | SCV005411288 | uncertain significance | not provided | 2024-09-19 | criteria provided, single submitter | clinical testing | PM2 |